Abstract
Depression is a common and potentially debilitating psychiatric disorder, and is twice as prevalent in women as in men. The traditional monoamine hypothesis of depression provides one perspective into the biological basis of depression, but it is unable to explain all facets of this disease. The reason for the sex difference is currently unclear. The endocannabinoid system, a major neuromodulatory system in the brain, interacts with multiple neurotransmitter and hormone systems, including the monoamine neurotransmitter norepinephrine. Increased endocannabinoid signaling appears to cause greater levels of noradrenergic activation in the locus coeruleus and in axons projecting into other parts of the brain. Dysfunctions in both the endocannabinoid system and the noradrenergic system have been linked to the physiology of depression, with the hypothalamic–pituitary–adrenal (HPA) axis stress response being a major area of interaction. Norepinephrine acts as a “gatekeeper” to the body’s stress response, mobilizing the HPA axis to react to stressors. The endocannabinoid system is also a “gatekeeper” to this response, preventing maladaptive HPA hyperactivation and potentially protecting the noradrenergic system from entering into a “burn-out” state in the face of chronic stress. Sexual dimorphism in both systems, as well as in how cells of the locus coeruleus respond to stress, may contribute to some of the sex differences seen in depression. Disruptions to these systems may underlie some cases of depression, and provide potential targets for novel antidepressant treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abercrombie ED, Jacobs BL (1987) Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I. Acutely presented stressful and nonstressful stimuli. J Neurosci 7:2837–2843
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-V. American Psychiatric Association, Washington
Aston-Jones G, Cohen JD (2005) An integrative theory of locus coeruleus-norpeinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 28:403–450
Atkinson HC, Leggett JD, Wood SA et al (2010) Regulation of the hypothalamic-pituitary-adrenal axis circadian rhythm by endocannabinoids is sexually diergic. Endocrinology 151:3720–3727
Bacci A, Huguenard JR, Prince DA (2004) Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431:312–316
Bangasser DA, Curtis A, Reyes BA et al (2010) Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry 15:877–904
Bangasser DA, Reyes BA, Piel D et al (2013) Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression. Mol Psychiatry 18:166–173
Berridge CW (2008) Noradrenergic modulation of arousal. Brain Res Rev 58:1–17
Best NR, Rees MP, Barlow DH, Cowen PJ (1992) Effect of estradiol implant on noradrenergic function and mood in menopausal subjects. Psychoneuroendocrinology 17:87–93
Bowman RE, Beck KD, Luine VN (2003) Chronic stress effects on memory: sex differences in performance and monoaminergic activity. Horm Behav 43:48–59
Carvalho AF, Van Bockstaele EJ (2012) Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 38:59–67
Carvalho AF, Mackie K, Van Brockstaele EJ (2010) Cannabinoid modulation of limbic forebrain noradrenergic circuitry. Eur J Neurosci 31:286–301
Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370:1706–1713
Conrad CD, Jackson JL, Wieczorek L et al (2004) Acute stress impairs spatial memory in male but not female rats: influence of estrous cycle. Pharmacol Biochem Behav 78:569–579
Curtis AL, Bethea T, Valentino RJ (2006) Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor. Neuropsychopharmacology 31:544–554
Dalla C, Antoniou K, Drossopoulou G et al (2005) Chronic mild stress impact: are females more vulnerable? Neuroscience 135:703–714
Dalla C, Antoniou K, Kokras N et al (2008a) Sex differences in the effects of two stress paradigms on dopaminergic neurotransmission. Physiol Behav 93:595–605
Dalla C, Edgecomb C, Whetstone AS, Shors TJ (2008b) Females do not express learned helplessness like males do. Neuropsychopharmacology 33:1559–1569
Dalla C, Pitychoutis PM, Kokras N, Papadopoulou-Daifoti Z (2010) Sex differences in animal models of depression and antidepressant response. Basic Clin Pharmacol Toxicol 106:226–233
Domschke K, Dannlowski U, Ohrmann P, Lawford B, Bauer J, Kugel H, Baune BT (2008) Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression. Eur Neuropsychopharm 18:751–759
Drossopoulou G, Antoniou K, Kitraki E etal (2004) Sex differences in behavioral, neurochemical and neuroendocrine effects induced by the forced swim test in rats. Neuroscience 126:849–857
Eisch AJ, Cameron HA, Encinas JM, Meltzer LA, Ming GL, Overstreet-Wadiche LS (2008) Adult neurogenesis, mental health, and mental illness: hope or hype? J Neurosci 28:11785–11791
Esteban S, García-Sevilla JA (2011) Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 38:78–87
Fisar Z (2010) Inhibition of monoamine oxidase activity by cannabinoids. Naunyn Schmiedebergs Arch Pharmacol 381:563–572
Flugge G, Van KM, Meyer H, Fuchs E (2003) Alpha2A and alpha2C-adrenoceptor regulation in the brain: alpha2A changes persist after chronic stress. Eur J Neurosci 17:917–928
Flugge G, Van KM, Mijnster MJ (2004) Perturbations in brain monoamine systems during stress. Cell Tissue Res 315:1–14
Foote SL, Bloom FE, Aston-Jones G (1983) Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63:844–914
Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Piomelli D (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci U S A 102:18620–18625
Goddard AW, Ball SG, Martinez J, Robinson MJ, Yang CR, Russell JM, Shekhar A (2010) Current perspectives of the roles of the central norepinephrine system in anxiety and depression. Depress Anxiety 27:339–350
Gorzalka BB, Dang SS (2012) Endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior. Endocrinology 153:1016–1024
Gorzalka BB, Hill MN (2009) Integration of endocannabinoid signaling into the neural network regulating stress-induced activation of the hypothalamic-pituitary-adrenal axis. Curr Top Behav Neurosci 1:289–306
Gorzalka BB, Hill MN (2011) Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry 35:1575–1585
Gorzalka BB, Hill MN, Chang SC (2010) Male–female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function. Horm Behav 58:91–99
Halbreich U, Sharpless N, Asnis GM et al (1987) Afternoon continuous plasma levels of 3-methoxy-4-hydroxphenylglycol and age. Distinctive biologic subgroups of endogenous depression? Arch Gen Psychiatry 44:804–812
Heinsbroek RP, van Haaren F, Feenstra MG et al (1991) Controllable and uncontrollable footshock and monoaminergic activity in the frontal cortex of male and female rats. Brain Res 551:247–255
Herkenham M, Lynn AB, De Costa BR, Richfield EK (1991) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res 547:267–274
Hill MN, Gorzalka BB (2005) Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test. Eur Neuropsychopharmacology 15:593–599
Hill MN, Gorzalka BB (2009) Impairments in endocannabinoid signaling and depressive illness. JAMA 301:1165–1166
Hill MN, Karacabeyli ES, Gorzalka BB (2007) Estrogen recruits the endocannabinoid system to modulate emotionality. Psychoneuroendocrinology 32:350–357
Hill MN, Miller GE, Ho WS, Gorzalka BB, Hillard CJ (2008) Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry 41:48–53
Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ (2009) Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology 34:1257–1262
Hill MN, McLaughlin RJ, Bingham B et al (2010) Endogenous cannabinoid signaling is essential for stress adaptation. Proc Natl Acad Sci U S A 107:9406–9411
Himmi T, Dallaporta M, Perrin J, Orsini JC (1996) Neuronal responses to delta 9-tetrahydrocannabinol in the solitary tract nucleus. Eur J Pharmacol 312:273–279
Himmi T, Perrin J, El Ouazzani T, Orsini JC (1998) Neuronal responses to cannabinoid receptor ligands in the solitary tract nucleus. Eur J Pharmacol 359:49–54
Horder J, Cowen PJ, Di Simplicio M, Browning M, Harmer CJ (2009) Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers. Psychopharmacology 205:85–91
Horder J, Harmer CJ, Cowen PJ, McCabe C (2010) Reduced neural response to reward following 7 days treatment with the cannabinoid CB(1) antagonist rimonabant in healthy volunteers. Int J Neuropsychopharmacol 13:1103–1113
Hungund BL, Vinod KY, Kassir SA et al (2004) Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 9:184–190
Itoi K, Sugimoto N (2010) The brainstem noradrenergic systems in stress, anxiety, and depression. J Neuroendocrinol 22:355–361
Jelsing J, Larson PJ, Vrang N (2008) Identification of cannabinoid type 1 receptor expressing cocaine amphetamine-regulated transcript neurons in the rat hypothalamus and brainstem using in situ hybridization and immunohistochemistry. Neuroscience 154:641–652
Jelsing J, Galzin AM, Guillot E, Pruniaux MP, Larsen PJ, Vrang N (2009) Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2. Brain Res Bull 78:202–210
Jentsch JD, Andrusiak E, Tran A et al (1997) Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966. Neuropsychopharmacology 16:426–432
Juhasz G, Chase D, Pegg E et al (2009) CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology 34:2019–2027
Justinova Z, Mangieri RA, Bortolato M et al (2008) Fatty acid amide hydrolase inhibition heightens anandamide signaling without reinforcing effects in primates. Biol Psychiatry 64:930–937
Karandrea D, Kittas C, Kitraki E (2002) Forced swimming differentially affects male and female brain corticosteroid receptors. Neuroendocrinology 75:217–226
Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Kendler HU (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8–19
Khan A, Brodhead AE, Schwartz KA, Kolts RL, Brown WA (2005) Sex differences in antidepressant response in recent antidepressant clinical trials. J Clin Psychopharmacol 25:318–324
Kitayama I, Yaga T, Kayahara T, Nakano K, Murase S, Otani M, Nomura J (1997) Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex. Biol Psychiat 42:687–696
Kitraki E, Kremmyda O, Youlatos D et al (2004) Gender-dependent alterations in corticosteroid receptor status and spatial performance following 21 days of restraint stress. Neuroscience 125:47–55
Kuehner C (2003) Gender differences in unipolar depression: an update of epidemiological findings and possible explanations. Acta Psychiatr Scand 108:163–174
Lambert G, Johansson M, Agren H, Friberg P (2000) Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness. Arch Gen Psychiat 57:787–793
Liu Y, Ishida Y, Shinoda K, Nakamura S (2003) Effects of repeated stress on regeneration of serotonergic and noradrenergic axons in the cerebral cortex of adult rats. Neurosci Lett 339:227–230
Llorente R, Llorente-Berzal A, Petrosino S et al (2008) Gender-dependent cellular and biochemical effects of materal deprivation on the hippocampus of neonatal rats: a possible role for the endocannabinoid system. Dev Neurobiol 68:1334–1347
López-Gallardo M, Llorente R, Llorente-Berzal A et al (2008) Neuronal and glial alterations in the cerebellar cortex of maternally deprived rats: gender differences and modulatory effects of two inhibitors of endocannabinoid inactivation. Dev Neurobiol 68:1429–1440
Lundberg U (2005) Stress hormones in health and illness: the roles of work and gender. Psychoneuroendocrinology 30:1017–1021
Mailleux P, Vanderhaeghen JJ (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655–668
Marsicano G, Wotjak CT, Azad SC et al (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530–534
Martel MM, Klump K, Nigg JT, Breedlove SM, Sisk CL (2009) Potential hormonal mechanisms of attention-deficit/hyperactivity disorder and major depressive disorder: a new perspective. Horm Behav 55:465–479
Matsuda LA, Bonner TI, Lolait SJ (1993) Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327:535–550
McKenna MT, Michaud CM, Murray CJ, Marks JS (2005) Assessing the burden of disease in the United States using disability-adjusted life years. Am J Prev Med 28:415–423
McLaughlin RJ, Hill MN, Gorzalka BB (2009) Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis. Eur J Pharmacol 624:71–76
Mendiguren A, Pineda J (2006) Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats. Eur J Pharmacol 534:83–88
Mendiguren A, Pineda J (2007) CB(1) cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices. Neuropharmacology 52:617–625
Mikics E, Vas J, Aliczki M, Halasz J, Haller J (2009) Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission. Behav Pharmacol 20:265–272
Monteleone P, Bifulco M, Maina G et al (2010) Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression. Pharmacol Res 61:400–404
Morrish AC, Hill MN, Riebe CJ, Gorzalka BB (2009) Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission. Physiol Behav 98:118–124
Muntoni AL, Pillola G, Melis M, Perra S, Gessa GL, Pistis M (2006) Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. Eur J Neurosci 23:2385–2394
Nelson JC (2008) Anxious depression and response to treatment. Am J Psychiatry 165:297–299
Ordway GA, Klimek V (2001) Noradrenergic pathology in psychiatric disorders: postmortem studies. CNS Spectr 6:697–703
Oropeza VC, Page ME, Van Bockstaele EJ (2005) Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex. Brain Res 1046:45–54
Oropeza VC, Mackie K, Van Brockstaele EJ (2007) Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res 1127:36–44
Page ME, Oropeza VC, Sparks SE et al (2007) Repeated cannabinoid administration increases indices of noradrenergic activity in rats. Pharmacol Biochem Behav 86:162–168
Patel S, Hillard CJ (2003) Cannabinoid-induced fos expression within A10 dopaminergic neurons. Brain Res 963:15–25
Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ (2004) Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145:5431–5438
Patel S, Roelke CT, Rademacher DJ, Hillard CJ (2005) Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur J Neurosci 21:1057–1069
Piccinelli M, Wilkinson G (2000) Gender differences in depression. Critical review. Br J Psychiatry 177:486–492
Pinos H, Collado P, Rodràguez-Zafra M et al (2001) The development of sex differences in the locus coeruleus of the rat. Brain Res Bull 56:73–78
Pitychoutis PM, Nakamura K, Tsonis PA et al (2009) Neurochemical and behavioral alterations in an inflammatory model of depression: sex differences exposed. Neuroscience 159:1216–1232
Rademacher DJ, Hillard CJ (2007) Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward. Prog Neuropsychopharmacol Biol Psychiatry 31:633–641
Rademacher DJ, Meier SE, Shi L, Ho WS, Jarrahian A, Hillard CJ (2008) Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 54:108–116
Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrie P (2004) CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 28:640–648
Reber SO, Birkeneder L, Veenema AH, Obermeier F, Falk W, Straub RH, Neumann ID (2007) Adrenal insufficiency and colonic inflammation after a novel chronic psycho-social stress paradigm in mice: implications and mechanisms. Endocrinology 148:670–682
Reich CG, Taylor ME, McCarthy MM (2009) Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behav Brain Res 203:264–269
Reyes BS, Rosario JC, Piana PT, Van Bockstaele EJ (2009) Cannabinoid modulation of cortical adrenergic receptors and transporters. J Neurosci Res 87:3671–3678
Rincavage HL, McDonnell DP, Kuhn CM (2003) Expression of functional estrogen receptor beta in locus coeruleus-derived Cath.a cells. Endocrinology 144:2829–2835
Rubino T, Vigano’ D, Realini N et al (2008) Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacology 33:2760–2771
Sanchis-Segura C, Cline BH, Marsicano G, Lutz B, Spanagel R (2004) Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology 176:223–232
Sara SJ (2009) The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10:211–223
Scavone JL, Mackie K, Van Brockstaele EJ (2010) Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors. Brain Res 1312:18–31
Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522
Servoa L, Rivkin M, Nakashima A, Sabban EL (2002) Estradiol stimulates gene expression of norepinephrine biosynthetic enzymes in rat locus coeruleus. Neuroendocrinology 75:193–200
Shansky RM, Bender G, Arnsten AF (2009) Estrogen prevents norepinephrine alpha-2a receptor reversal of stress-induced work memory impairment. Stress 12:457–463
Shors TJ, Chua C, Falduto J (2001) Sex differences and opposite effects of stress on dendritic spine density in the male versus female hippocampus. J Neurosci 21:6292–6297
Shors TJ, Mathew J, Sisti HM et al (2007) Neurogenesis and helplessness are mediated by controllability in males but not females. Biol Psychiatry 62:487–495
Steiner MA, Wanisch K, Monory K et al (2008a) Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics J 8:196–208
Steiner MA, Marsicano G, Wotjak CT, Lutz B (2008b) Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses. Psychoneuroendocrinology 33:1165–1170
Sun MK, Alkon DL (2006) Differential gender-related vulnerability to depression induction and converging antidepressant responses in rats. J Pharmacol Exp Ther 316:926–932
Suárez J, Llorente R, Romero-Zerbo SY et al (2009) Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. Hippocampus 7:623–632
Tzavara ET, Perry KW, Rodriguez DE et al (2001) The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus. Eur J Pharmacol 426:R3–R4
Tzavara ET, Davis RJ, Perry KW et al (2003) The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br J Pharmacol 138:544–553
Valdizán EM, Mato S, González-Maeso J et al (2011) Functionality of cannabinoid receptors in the prefrontal cortex of major depression suicide victims: influence of antidepressant treatment at the time of death. In: XIV Congreso Nacional Sociedad Española de Neurociencia (SENC), Salamanca, abstract P-105
Van Laere K, Goffin K, Casteels C et al (2008) Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. Neuroimage 39:1533–1541
Wood GE, Shors TJ (1998) Stress facilitates classical conditioning in males, but impairs classical conditioning in females through activational effects of ovarian hormones. Proc Natl Acad Sci U S A 95:4066–4071
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gorzalka, B., Dang, S. (2013). Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function. In: Van Bockstaele, E. (eds) Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7940-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7940-6_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7939-0
Online ISBN: 978-1-4614-7940-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)